Post-quantum cryptography standards highlight the need for governments to prepare for emerging quantum computing risks. Previously considered a distant concern, quantum computers may soon compromise the government’s most sensitive data. Here's how to get ready.
Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.
Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
Leading smart infrastructure solutions company Costain discusses the countless benefits of setting up the right data-sharing platform to help organisations transform business performance and meet carbon reduction targets.
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
Rami Cassis, Founder and CEO of Parabellum Investments, discusses the dangers of relying on technology to judge how well an employee is performing and also looks at which cultures expect different things from their HR leaders.
The illegal mining of the Amazon rainforest continues through the COVID pandemic, with Indigenous communities experiencing the double-hit of mercury poisoning and "imminent violence".
When rethinking service transformation, the focus should be on reshaping - Christopher Sly, AVP, Digital Transformation, HGS UK, explains why knowing the limitations to emerging tech reshapes a far greater value story.
The US is facing a fourth wave of COVID-19, as emergency healthcare workers across the country continue to face the virus and experience levels of burnout that can lead to PTSD.
New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.
Chris Norton, Managing Director, UK & Ireland, InterSystems, discusses the NHS’ current challenges, integrated care efforts, and the ways data and technology can be harnessed to inform care today, and in a post-COVID world.
Today (8 April) it was revealed that over 700,000 AstraZeneca doses manufactured in the UK are being sent to Australia - with a confirmed 300,000 vaccines in Sydney at the end of February.
New data from the REACT study finds that the prevalence of COVID is down by 60% in one month, but primary school children have the highest COVID infection levels.
